Impelsys, the American Heart Association (Association) and Laerdal have worked closely together for a decade, through a collaboration with Impelsys-MedLern’s parent company
The American Heart Association’s subsidiary Healthcare Quality and Research Systems (HQRS), and Laerdal Medical have invested in Medlern.
Impelsys, the American Heart Association (Association) and Laerdal have worked closely together for a decade, through a collaboration with Impelsys-MedLern’s parent company.
Deepak Sharma, Co-founder and CEO, MedLern said, “HQRS and Laerdal bring the latest innovations and evidence-based tools and content to drive high quality training in healthcare settings globally. India’s healthcare sector needs to leapfrog the world in innovation to create the skilled manpower to serve the largest and most diverse demographic in the world. We need scale and vision. The new collaborations open up access to an impressive pipeline of healthcare training innovation are we are committed to make this affordable and rewarding for hospital leaders in India.”
John Meiners, HQRS and Chief of Mission Aligned Businesses & Healthcare Solutions at the American Heart Association said, “Every year, nearly a hundred thousand Indian doctors, nurses and other healthcare professionals are trained on the Association’s BLS, ACLS and PALS programs but that is still a small fraction of what the country needs. With MedLern’s support, we believe we will have the scale to reach our solutions to the wider ecosystem and save many more lives. In the US, we train 22 million people in CPR every year and in the last 5 years alone, we have helped reduce deaths from stroke by 13.6 per cent and deaths from heart disease by 14.1 per cent. We are also very excited about the prospect of bringing our portfolio of evidence-based tools, guidelines and CME content to benefit the Indian ecosystem in the future.”
“We work with enabling technologies, collaborative initiatives, and early interventions with high life saving potential and low cost to society. Our strategic investment in MedLern brings us closer to bringing scalable solutions to a developing market in the most populous country in the world.” said Alf Christian Dybdahl, CEO of Laerdal Medical.
Sameer Shariff, founder of Impelsys and Chairman and Co-founder of MedLern said, “I believe India has the potential to not just improve the quality of healthcare delivery to its own citizens but also contribute to the future of global healthcare. I am looking forward to the exciting and impactful journey ahead.”
The investment in MedLern is made through the organisation’s wholly owned subsidiary, Healthcare Quality and Research Systems, Inc. (HQRS).